On Thursday, Rite Aid Corporation (NYSE:RAD)’s shares declined -2.35% to $7.88.
Rite Aid Corporation (RAD) offered 40.80% EPS for prior five years. The company has -686.80% return on equity value while its ROI ratio was 43.90%. The company has $8.43 billion market capitalizations and the institutional ownership was 61.00%. Its price to book ratio was -18.76. Volatility of the stock was 11.21% for the week while for the month booked as 5.60%.
Rite Aid Corporation, declared sales results for October.
Monthly Sales
For the four weeks ended Oct. 24, 2015, same store sales raised 1.0 percent over the prior-year period. October front-end same store sales reduced 0.5 percent. Pharmacy same store sales, which comprised an approximate 249 basis points negative impact from new generic introductions, raised 1.7 percent. Prescription count at comparable stores raised 0.2 percent over the prior-year period.
Total drugstore sales for the four-week period raised 1.4 percent to $2.086 billion contrast to $2.058 billion for the same period last year. Prescription sales accounted for 70.7 percent of drugstore sales, and third party prescription sales represented 97.9 percent of pharmacy sales.
Year-to-Date
Same store sales for the 34-week period ended Oct. 24, 2015 raised 2.2 percent over the prior-year period. Front-end same store sales raised 0.3 percent while pharmacy same store sales raised 3.0 percent. Prescription count at comparable stores raised 0.6 percent over the prior-year period.
Total drugstore sales for the 34 weeks ended Oct. 24, 2015 raised 2.2 percent with sales of $17.350 billion contrast to $16.982 billion for the same period last year. Prescription sales represented 69.5 percent of total drugstore sales, and third party prescription sales represented 97.8 percent of pharmacy sales.
Rite Aid Corporation is a retail drugstore chain. The Company sells prescription drugs and a range of other merchandise, which are referred to as front-end products. The Company’s drugstores’ primary business is pharmacy services. It operates about 4,570 stores in 31 states across the country and in the District of Columbia.
Monster Worldwide, Inc. (NYSE:MWW)’s shares dropped -13.64% to $6.33.
Monster Worldwide, Inc. (MWW) has beta value of 2.59. The company has the market capitalization of $670.39 million. Return on assets ratio of the company was -22.20% while its return on equity ratio was -57.20%. ATR value of company was 0.34 while stock volatility for week was 6.10% while for month was 4.45%. Debt to equity ratio of the company was 0.49 and its current ratio was 1.00.
Monster Worldwide, stated financial results for the third quarter and nine months ended September 30, 2015. Third quarter 2015 financial results reflect the completion of the Company’s remaining ownership stake in JobKorea, the Company’s South Korean operations, which were classified as a suspended operation.
Third Quarter 2015 Results
Revenue from ongoing operations of $167 million reduced 3% at constant currency contrast to last year’s third quarter and reduced 7% at actual rates. Revenue from the Company’s Careers – North America operations reduced 4% year over year. Revenue from Careers – International was essentially flat year over year at constant currency and reduced 13% at actual rates. As of the first quarter of 2015, Internet Advertising & Fees revenue and operating results are being stated within the Careers – North America segment. Historical quarterly revenue data is available in the Company’s supplemental financial information.
Total GAAP operating expenses from ongoing operations reduced to $156 million contrast to $180 million in the third quarter of 2014. Net income from ongoing operations for the third quarter of 2015 was $10 million, or $0.11 per share, contrast to a loss from ongoing operations of $3 million, or $0.03 per share in the third quarter of 2014.
Non-GAAP net income from ongoing operations was $10 million, or $0.11 per share, contrast to $4 million, or $0.04 per share in the third quarter of 2014. Non-GAAP operating expenses of $150 million reduced 13% year over year. Adjusted EBITDA margin of 16.8% was led by Careers – North America with a 29% margin.
Monster Worldwide, Inc. is engaged in connecting people to jobs. The Company offers services in over 40 countries, providing job seeking, career administration, recruitment and talent administration capabilities. The Company operates in three segments: Careers-North America, Careers-International and Internet Advertising & Fees.
At the end of Thursday’s trade, AbbVie Inc (NYSE:ABBV)‘s shares surged 1.60% to $54.11.
AbbVie Inc (ABBV) has market value of $88.16 billion while its EPS was booked as $1.28 in the last 12 months. The stock has 1.66 billion shares outstanding while 75.30% shares of the company were owned by institutional investors. In the profitability analysis, the company has gross profit margin of 80.70% while net profit margin was 9.90%.
AbbVie Inc. (AbbVie) is a global, research-based biopharmaceutical company. The Company develops and markets therapies that address a range of diseases. The Company’s products are focused on treating conditions, such as chronic autoimmune diseases, counting rheumatoid arthritis, psoriasis and Crohn’s disease; hepatitis C (HCV); human immunodeficiency virus (HIV); endometriosis; thyroid disease; Parkinson’s disease; complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone.